Cargando…
Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials
Randomized control trialsare the gold standard for testing the efficacy of new interventions. Historically, superiority trials were methods of choice as reference (standard) interventions were not established for many disease conditions. However currently, reference interventions are available for m...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734976/ https://www.ncbi.nlm.nih.gov/pubmed/33344335 http://dx.doi.org/10.4103/idoj.IDOJ_130_20 |
_version_ | 1783622574417117184 |
---|---|
author | Kishore, Kamal Mahajan, Rahul |
author_facet | Kishore, Kamal Mahajan, Rahul |
author_sort | Kishore, Kamal |
collection | PubMed |
description | Randomized control trialsare the gold standard for testing the efficacy of new interventions. Historically, superiority trials were methods of choice as reference (standard) interventions were not established for many disease conditions. However currently, reference interventions are available for most of adverse conditions. Despite this, many investigators are using superiority trials in comparison to more suitable noninferiority and equivalence trials. The application of noninferiority and equivalence trials is on the rise, but by and large, these trials are poorly understood, ill-conceived, inappropriately analyzed, and reported and misinterpreted. |
format | Online Article Text |
id | pubmed-7734976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-77349762020-12-18 Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials Kishore, Kamal Mahajan, Rahul Indian Dermatol Online J Review Article Randomized control trialsare the gold standard for testing the efficacy of new interventions. Historically, superiority trials were methods of choice as reference (standard) interventions were not established for many disease conditions. However currently, reference interventions are available for most of adverse conditions. Despite this, many investigators are using superiority trials in comparison to more suitable noninferiority and equivalence trials. The application of noninferiority and equivalence trials is on the rise, but by and large, these trials are poorly understood, ill-conceived, inappropriately analyzed, and reported and misinterpreted. Wolters Kluwer - Medknow 2020-09-19 /pmc/articles/PMC7734976/ /pubmed/33344335 http://dx.doi.org/10.4103/idoj.IDOJ_130_20 Text en Copyright: © 2020 Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Kishore, Kamal Mahajan, Rahul Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials |
title | Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials |
title_full | Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials |
title_fullStr | Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials |
title_full_unstemmed | Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials |
title_short | Understanding Superiority, Noninferiority, and Equivalence for Clinical Trials |
title_sort | understanding superiority, noninferiority, and equivalence for clinical trials |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734976/ https://www.ncbi.nlm.nih.gov/pubmed/33344335 http://dx.doi.org/10.4103/idoj.IDOJ_130_20 |
work_keys_str_mv | AT kishorekamal understandingsuperioritynoninferiorityandequivalenceforclinicaltrials AT mahajanrahul understandingsuperioritynoninferiorityandequivalenceforclinicaltrials |